Who owns SILENCE THERAPEUTICS PLC?
- Ticker: SLN
- CUSIP Number: 82686q101
Tip: Access positions for across all investors
Analyze quarterly positions in Silence Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Silence Therapeutics stock
Who bought or sold SILENCE THERAPEUTICS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| TCG Crossover Management | 3.3M | $63M | 0% | Jun 2024 |
|
| Siren | 2.8M | $52M | 100% | Sep 2024 |
|
| Redmile Group | 1.9M | $35M | -6% | Sep 2024 |
|
| Logos Global Management | 1.5M | $28M | 0% | Jun 2024 |
|
| Deep Track Capital | 1.4M | $26M | -17% | Jun 2024 |
|
| Frazier Life Sciences Management | 1.1M | $21M | 0% | Sep 2024 |
|
| Nextech Invest | 952k | $17M | 0% | Sep 2024 |
|
| Henderson Group | 819k | $16M | 31% | Jun 2024 |
|
| Eventide Asset Management | 640k | $12M | 100% | Sep 2024 |
|
| Cormorant Asset Management | 625k | $12M | 0% | Jun 2024 |
|
| Ikarian Capital | 587k | $3.4M | 16% | Sep 2024 |
|
| 5AM Venture Management | 476k | $8.7M | 0% | Sep 2024 |
|
| Point72 Asset Management | 468k | $8.5M | 219% | Sep 2024 |
|
| Citadel Advisors | 439k | $8.0M | 276% | Sep 2024 |
|
| Woodline Partners | 407k | $7.4M | 348% | Sep 2024 |
|
| Duquesne Family Office | 387k | $7.0M | 0% | Sep 2024 |
|
| SG Americas Securities | 343k | $6.2M | 0% | Sep 2024 |
|
| ExodusPoint Capital Management | 339k | $6.2M | 100% | Sep 2024 |
|
| Cantor Fitzgerald, L. P. | 334k | $6.1M | 35% | Sep 2024 |
|
| Aquilo Capital Management | 317k | $5.8M | -37% | Sep 2024 |
|
| Morgan Stanley | 304k | $5.8M | 25% | Jun 2024 |
|
| Parkman Healthcare Partners | 290k | $5.5M | 19% | Jun 2024 |
|
| T. Rowe Price Associates | 229k | $4.2M | 100% | Sep 2024 |
|
| Nantahala Capital Management | 200k | $3.6M | 0% | Sep 2024 |
|
| M28 Capital Management | 185k | $3.4M | 0% | Sep 2024 |
|
| Hsbc Holdings | 178k | $3.4M | 0% | Jun 2024 |
|
| Marshall Wace | 168k | $3.1M | 13% | Sep 2024 |
|
| Schonfeld Strategic Advisors | 166k | $3.0M | 121% | Sep 2024 |
|
| Two Sigma Investments | 99k | $1.9M | -8% | Jun 2024 |
|
| Two Sigma Advisers | 76k | $1.4M | -2% | Jun 2024 |
|
| Citigroup | 58k | $1.1M | 0% | Sep 2024 |
|
| Artia Global Partners | 53k | $954k | 0% | Sep 2024 |
|
| NEOS Investment Management | 52k | $940k | 344% | Sep 2024 |
|
| Cubist Systematic Strategies | 46k | $842k | 391% | Sep 2024 |
|
| TD Asset Management | 31k | $559k | 100% | Sep 2024 |
|
| Geode Capital Management | 29k | $535k | 0% | Sep 2024 |
|
| Y-Intercept | 21k | $383k | 23% | Sep 2024 |
|
| William Blair $ Company | 20k | $364k | -21% | Sep 2024 |
|
| Rathbones Brothers | 18k | $350k | -7% | Jun 2024 |
|
| Goldman Sachs Group | 16k | $309k | -25% | Jun 2024 |
|
| Custom Index Systems | 14k | $262k | -3% | Sep 2024 |
|
| Advisor Group Holdings | 13k | $239k | 20% | Sep 2024 |
|
| Vestcor Investment Management Corp | 8.8k | $160k | 100% | Sep 2024 |
|
| Quarry | 6.0k | $114k | 100% | Jun 2024 |
|
| Barclays | 3.3k | $61k | -40% | Sep 2024 |
|
| Values First Advisors | 3.1k | $56k | 100% | Sep 2024 |
|
| Royal Bank of Canada | 1.9k | $36k | -59% | Sep 2024 |
|
| Bank of America Corporation | 1.0k | $19k | -90% | Sep 2024 |
|
| GAMMA Investing | 859.00 | $16k | 0% | Sep 2024 |
|
| Rhumbline Advisers | 754.00 | $14k | 61% | Sep 2024 |
|
| Steward Partners Investment Advisory | 100.00 | $1.9k | 0% | Jun 2024 |
|
| Wells Fargo & Company | 19.00 | $345.000100 | 100% | Sep 2024 |
|
Who sold out of Silence Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Artal Group | Jun 2024 | 2.8M | $53M |
| Millennium Management | Jun 2024 | 783k | $15M |
| Hudson Bay Capital Management | Jun 2024 | 208k | $4.0M |
| Octagon Capital Advisors | Jun 2024 | 176k | $3.3M |
| Stempoint Capital | Jun 2024 | 125k | $2.4M |
| Renaissance Technologies | Jun 2024 | 39k | $743k |
| New York State Common Retirement Fund | Jun 2024 | 24k | $457k |
| Trexquant Investment | Jun 2024 | 22k | $414k |
| Legato Capital Management | Jun 2024 | 20k | $376k |
| Shay Capital | Mar 2024 | 15k | $327k |
| Jump Financial | Jun 2024 | 12k | $235k |
| Advisors Preferred | Jun 2024 | 5.3k | $100k |
| Qube Research & Technologies | Mar 2024 | 3.9k | $85k |
| Lazard Asset Management | Jun 2024 | 60.00 | $1.0k |